News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56 Results
Section
Business (24)
Deals (5)
Drug Development (2)
FDA (1)
News (39)
Policy (10)
Tag
Alliances (8)
Approvals (1)
Clinical research (1)
Diagnostics (1)
Earnings (10)
Events (4)
FDA (1)
Healthcare (2)
IPO (1)
Legal (8)
Mergers & acquisitions (4)
People (6)
Phase III (1)
Postmarket research (1)
Regulatory (2)
Date
2022 (2)
2021 (1)
2020 (5)
2019 (1)
2018 (2)
2017 (5)
2016 (2)
2015 (1)
2014 (1)
2011 (3)
2010 (6)
56 Results for "spepharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
SpePharm AG Wins Case Against Eisai Inc. in United States District Court for District of Delaware
SpePharm AG, a subsidiary of Norgine B.V., announced that the United States District Court for the District of Delaware ruled on 4th September 2019 in favour of SpePharm in its proceeding against Eisai Inc., upholding SpePharm’s licensed rights for SALAGEN® through April 2026.
September 9, 2019
·
2 min read
Policy
Onxeo Provides Update on Litigation with SpeBio/SpePharm
Onxeo announces that it has submitted its conclusions to the Paris Court of Appeal concerning merits of the litigation against SpePharm/SpeBio B.V companies to ensure that the appeals process proceeds as expeditiously as possible for the benefit of its shareholders.
January 23, 2018
·
3 min read
Policy
Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm
The Court ordered Onxeo to pay SpeBio for costs incurred before termination the sum of 8.6 million euros with capitalized interest at the legal rate as of June 30, 2014.
October 18, 2017
·
5 min read
Deals
Clinigen Group Acquires Oncology Support Therapy SAVENE® (Dexrazoxane) From SpePharm
March 31, 2014
·
1 min read
Business
SpePharm Sells Japanese Rights for Savene(R) to Kissei Pharmaceutical Co., Ltd.
September 1, 2011
·
3 min read
Business
Nicox Appoints Jean-Francois Labbé as Chairman of the Board of Directors
Nicox SA, an international ophthalmology company, announced that Jean-Francois Labbé, a Board member of Nicox SA, has been appointed as Chairman of the Nicox Board of Directors, effective July 28, 2022.
July 29, 2022
·
4 min read
Deals
JHP Pharmaceuticals and SpePharm Complete Purchase of Dantrium
August 21, 2008
·
2 min read
Lone Star Bio
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
July 27, 2009
·
1 min read
Deals
JHP Pharmaceuticals and SpePharm Complete Purchase of Dantrium(R)
August 20, 2008
·
1 min read
Lone Star Bio
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
June 30, 2009
·
3 min read
1 of 6
Next
